James Christopher Costello
NIH Rank #10944
- R01 Holder
- Translational
- Early Career
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10562004Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$873.2K
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#10,944
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing James Christopher Costello as a PI. Multi-PI records show the full award amount for context.
- 5R01CA268055-05R01NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer$501.6Kaward amount
- 5T32GM158468-02T32Predoctoral Training Grant in Pharmacology and Molecular Medicine$345.2Kaward amount
- $26.4Kaward amount
Award organization
Organizations that administered FY2026 awards listing James Christopher Costello as a PI.
FY2026 award administered by University of Colorado (CO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Colorado
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #7778
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as James Christopher Costello.